Debiopharm, Ipsen Extend Partnership for Patient Access to Decapeptyl
News
The pharmaceutical companies Debiopharm and Ipsen have extended their agreement for the development, manufacturing, and distribution of Decapeptyl (triptorelin), used in the treatment of endometriosis. This partnership, which began in ... Read more